Pfizer Inc
NYSE: PFE
$29.42
-$0.24 (-0.8%)
Closing Price on September 20, 2024
PFE Articles
If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech company, it would be in a successful treatment of Alzheimer's disease.
Published:
Last Updated:
Apple and 3M weighed on the DJIA Wednesday while McDonald's and Pfizer gave the index a boost.
Published:
Last Updated:
United Technologies, Pfizer, Merck, and Boeing were the stalwarts among the DJIA index stocks on Thursday.
Published:
Last Updated:
Although the markets were mixed on Thursday, major drug manufacturers proved to be one of the more positive segments on the day.
Published:
Last Updated:
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Pfizer, Goldman Sachs, JPMorgan Chase, and Caterpillar helped boost the DJIA to another gain Tuesday.
Published:
Last Updated:
DuPont, General Electric, Pfizer, and UnitedHealth were the leading DJIA gainers Thursday.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks dropped.
Published:
Last Updated:
Nike, Cisco Systems, Home Depot, and Pfizer put the most downward pressure on the DJIA Friday.
Published:
Last Updated:
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
A few analysts released reports this past week calling for these three Dow stocks to rise even higher (at least 10%).
Published:
Last Updated:
The DJIA was headed for a nearly flat close Thursday, with Pfizer and UnitedHealth offsetting share price declines at Apple and DuPont.
Published:
Last Updated:
A few analysts released reports Wednesday calling for three Dow stocks to rise even higher. It seems at this rate that 23,000 is just around the corner.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday include Apple, Caterpillar, Pfizer, Royal Caribbean, Shopify, Under Armour and Walmart.
Published:
Last Updated:
Pharmaceuticals maker Pfizer reported second-quarter earnings before markets opened Tuesday, beating profit estimates by a penny a share, but coming up short on revenues.
Published:
Last Updated: